Advertisement
Advertisement
Money /
Investment Products
Related Topics:
Stocks
Banking & finance
China’s private sector
US reshoring drive casts shadow over China’s contract drug makers, analyst says
Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.
18 Mar 2026 - 10:10AM
Banking & finance
Hong Kong export credit insurer keeps premiums low despite Middle East tensions
12 Mar 2026 - 7:00PM
Two Sessions 2026
Healthcare investors looking to ‘two sessions’ for clarity on drug pricing
4 Mar 2026 - 9:05AM
IPO
HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings
Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.
3 Mar 2026 - 6:43PM
Bull statues are seen in front of the Shenzhen Stock Exchange on November 17, 2024. Photo: Getty Images
Made in China 2025
Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals
Chinese pharmaceutical firms are poised for profit growth, driven by innovative drug sales and licensing deals, despite pricing pressures.
1 Mar 2026 - 12:00PM
Hong Kong stock market
The big cornerstone comeback: what’s driving investors back to Hong Kong IPOs?
After four subdued years, the cornerstone investors that anchor Hong Kong’s IPO market are returning in force, reshaping the deal landscape.
28 Feb 2026 - 1:44PM
Advertisement
Advertisement
Advertisement
Made in China 2025
Chinese healthcare firms expand overseas to support growing expat community
Privately owned Distinct Healthcare plans to open a clinic in Dubai, while TCM group Gushengtang eyes 50 centres in Southeast Asia.
11 Feb 2026 - 5:08PM
Distinct Healthcare raised HK$284.53 million from its initial public offering in Hong Kong last week. Photo: Handout
Banking & finance
Mainland China’s investors pour into Hong Kong-listed drug stocks
An index tracking Stock Connect buying of 40 mainland drug firms gains 9 per cent in a week as China’s industry heft grows.
10 Feb 2026 - 4:31PM
Made in China 2025
Fosun Pharma unit licenses lung cancer drug to Eisai in US$1.55 billion deal
The deal comes as Chinese novel drug makers are having more say in how their new medicines are developed with global partners.
6 Feb 2026 - 5:00PM
Banking & finance
Chinese gold, silver investors face gut check amid volatility, fund suspensions
Some retreat to the sidelines as another fund suspends new investments and futures plunge, while others remain determined to buy the dip.
3 Feb 2026 - 9:54AM
Hong Kong property
SHKP posts another Sierra Sea sell-out as Hong Kong property rebound strengthens
Fifth consecutive sell-out at Sai Sha development shows recovery gathering pace, with analysts forecasting further price increases ahead.
1 Feb 2026 - 8:32PM
The latest Sierra Sea offering includes 244 two-bedroom and 106 three-bedroom units. Photo: Edmond So
Banking & finance
The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs
A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.
5 Jan 2026 - 11:08AM
Fintech
Digital finance in 2026: what to expect as pilots move into real-world adoption
While digital money experiments promise greater efficiency, they also risk deeper fragmentation and regulatory pitfalls, experts warn.
5 Jan 2026 - 7:30AM
Made in China 2025
China’s rising biotech clout on show in flurry of billion-dollar licensing deals
A burst of overseas licensing pacts is spotlighting China’s biotech sector, as Jacobio, Coherent Biopharma and Harbour BioMed land deals.
26 Dec 2025 - 10:47AM
Banking & finance
Gold takes centre stage as Hong Kong builds commodities ecosystem
Hong Kong plans to build an international gold trading centre as part of a wider commodities hub push.
22 Dec 2025 - 7:15PM
Gold bricks displayed at Hong Kong Gold Exchange Chinese New Year Opening Ceremony in Sheung Wan. Photo: Edmond So
Banking & finance
Hong Kong launches HKEX Tech 100 Index in pivot towards innovation-driven growth
Unveiling of benchmark tracking Hong Kong-listed tech firms comes amid a wave of property stock delistings.
9 Dec 2025 - 5:51PM
Wealth management
China’s rich step up offshore bets as gold and insurance gain favour
China’s wealthy are shifting more of their portfolios offshore, as they seek to hedge slowing growth, policy risks and low yields at home.
4 Dec 2025 - 7:00PM
Advertisement
Advertisement
Advertisement
Banking & finance
China’s JD.com unit Jingdong Industrials aims for US$412 million Hong Kong IPO
Seven cornerstone investors led by London-based M&G Investments pledge a total of US$170 million.
3 Dec 2025 - 3:14PM
JD.com will retain a 72 per cent stake after the listing. Photo: Reuters
Banking & finance
From chips to noodles: the newcomers testing Hong Kong’s buoyant IPO market
A wave of billion-dollar offerings is building behind four new listings this week, signalling sustained momentum in Hong Kong’s IPO market.
3 Dec 2025 - 7:30AM
Banking & finance
Hong Kong taps Value Partners, 9 others to manage US$385 million residency fund
Government investment arm HKIC also names Primavera among managers of CIES IP, which focuses on Hong Kong’s long-term development.
2 Dec 2025 - 3:36PM
Banking & finance
Hong Kong retail funds hit record pace, surpass 2024 full-year total
Gross sales reach US$82.6 billion in the first three quarters as investors pile into fixed-income funds: HKIFA.
26 Nov 2025 - 6:21PM
Fintech
Hong Kong and Malaysian firms launch tokenised AI infrastructure fund
‘World’s first’ global-grade AI infrastructure tokenised fund gives investors access to growing demand from Asean: Tykhe and Skyvast.
24 Nov 2025 - 6:30PM
The launch comes after Hong Kong unveiled a five-year fintech strategy earlier this month, pledging to advance AI and tokenisation initiatives. Photo: Shutterstock
Banking & finance
Asia-Pacific investors brace for market correction in 2026: survey
Top concerns include a potential tech bubble, geopolitical tensions and recession, according to Natixis.
20 Nov 2025 - 2:22PM
IPO
China’s Unitree Robotics completes pre-IPO tutoring for onshore listing
The unicorn is reportedly aiming for a valuation of up to US$7 billion in a listing on Shanghai’s Nasdaq-style Star Market.
17 Nov 2025 - 3:07PM
videocam
Banking & finance
Adams Street joins wave of investment firms opening in Hong Kong
‘We want to be closer to both our investors and the investment opportunities that are presenting themselves here,’ managing partner says.
17 Nov 2025 - 8:30AM
Help preserve 120 years of quality journalism.
SUPPORT NOW
